Anteris Technologies Global Corp. (Anteris or the Company) (NASDAQ: AVR, ASX: AVR) a global structural heart company committed ...

Anteris Technologies Global Corp. (Anteris or the Company) a global structural heart company committed to designing, developing, and commercializing cutting-edge medical devices to restore healthy ...

In January 2025, the Securities and Exchange Commission (the Commission) approved amendments to the minimum bid price compliance rules for ...

Discover Monster Beverage's growth strategies amidst fierce competition. Explore market trends, challenges, and MNST stock's ...

Strong returns in U.S. stocks, particularly over the past two plus years, have led investors to question the relative lack of ...

Despite reporting positive Phase II results for its lead candidate last year, Vaccinex will soon no longer be a publicly ...

There is a healthy pipeline of U.S. initial public offerings, but investors are looking for more certainty in markets, Adena ...

Alphatec Holdings continues to benefit from M&A-related disruptions at key competitors. Read why I reiterate Buy rating for ...

Docebo's Q4 2024 results beat revenue and earnings estimates, but forward revenue growth guidance has become tepid. Explore ...

Additionally, as a result of the Company’s market value of publicly held shares being $5,000,000 or above during the same period, the Company has regained compliance with Nasdaq Listing Rule 5450 (b) ...

Company receives approval for Nasdaq or NYSE listing after Beijing’s pledge to help more mainland companies raise funds.

China clamps down on small-cap U.S. listings by Chinese issuers; China mandates personal information protection compliance ...